# Benitec Biopharma Inc. (BNTC) fundamentals

Data as of 2026-11-05. NASDAQ, United States. Sector: Healthcare / Biotechnology. Price $8.80, market value $307 million.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Benitec Biopharma Inc. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / book: 1.7×**. The shares trade at 1.7× book value; book value is a meaningful part of the valuation.

## Profitability
- **Return on equity: -25.7%**. Return on equity is negative because earnings are negative.
- **Return on assets: -11.9%**. Each dollar of assets produces -11.9% of profit.

## Growth
- **EPS growth (1 yr): 6.7%**. Earnings per share rose 6.7%.

## Financial health
- **Current ratio: 34.00** (quick 34.00). Current assets cover the next year's liabilities 34.00 times.
- **Piotroski F-score: 2/9**. 2 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend: none**. Benitec Biopharma Inc. does not currently pay a dividend.

## Analyst view
- **Analyst consensus: strong_buy** (7 analysts). 7 analysts cover Benitec Biopharma Inc.; the consensus is strong_buy, with an average price target of $23.29 (+164% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): -40.9%** (YTD -31.1%, 3-mo -26.9%). The shares are down 40.9% over twelve months including dividends.
- **From 52-week high: -38.8%** (11.7% above the low). Trading 39% below its 52-week high, deep in a drawdown.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 52**. An RSI of 52 is neutral.
- **Beta (1 yr): 1.37** (volatility 61%). Beta of 1.37 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=BNTC · Page: https://foliofundamentals.com/stocks/bntc

Not investment advice.